Adaptive Biotechnologies Corp vs BHP Billiton Limited — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while BHP Billiton Limited trades at $90.9 (market cap $229.15B). The key difference: BHP Billiton Limited is far larger — about 56.7× Adaptive Biotechnologies Corp's market cap, and BHP Billiton Limited pays a 2.95% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | BHP | |
|---|---|---|
Market Cap | $4.04B | $229.15B |
Sector | Health | Basic Materials |
52-Week High | $25.45 | $93.15 |
52-Week Low | $12.30 | $52.14 |
Enterprise Value | $4.10B | $243.35B |
Dividend Yield | — | 2.95% |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.
Read more on BHP →